Streetbeat News

Analyst Ratings

CNOB

Raymond James analyst Daniel Tamayo has upgraded ConnectOne Bancorp (NASDAQ:CNOB) from Market Perform to Strong Buy and announced a $26 price target.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 10:40 am

ADBE

Morgan Stanley analyst Keith Weiss has upgraded Adobe (NASDAQ:ADBE) from Equal-Weight to Overweight and raised the price target from $510 to $660.

Portfolio Pulse from richadhand@benzinga.com

July 31, 2023 | 10:39 am

IMGN

Immunogen reported Q2 earnings per share of $(0.02), beating the analyst consensus estimate of $(0.16) by 87.5%. The company also reported quarterly sales of $83.15 million, surpassing the analyst consensus estimate of $42.84 million by 94.10%. This represents a 487.16% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 10:31 am

CNC

Barclays analyst Steve Valiquette has maintained an Overweight rating on Centene (NYSE:CNC) but lowered the price target from $86 to $85.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 31, 2023 | 10:31 am

BAH

Barclays analyst Colin Canfield maintains an Equal-Weight rating on Booz Allen Hamilton (NYSE:BAH) and raises the price target from $108 to $125.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 31, 2023 | 10:30 am

AVTR

Barclays analyst Luke Sergott maintains an Overweight rating on Avantor (NYSE:AVTR) and raises the price target from $22 to $23.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 31, 2023 | 10:27 am

OTLY

Barclays analyst Andrew Lazar has maintained an Overweight rating on Oatly Group (NASDAQ:OTLY) but lowered the price target from $3 to $2.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 31, 2023 | 10:24 am

HUBG

Barclays analyst Brandon Oglenski maintains an Equal-Weight rating on Hub Group (NASDAQ:HUBG) and raises the price target from $80 to $90.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 31, 2023 | 10:23 am

AMBP

Barclays analyst Michael Leithead maintains an Overweight rating on Ardagh Metal Packaging (NYSE:AMBP) but lowers the price target from $6 to $5.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 31, 2023 | 10:21 am

BSX

Barclays analyst Matt Miksic maintains an Overweight rating on Boston Scientific (NYSE:BSX) and raises the price target from $56 to $59.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 31, 2023 | 10:20 am